Phase II Study of the Hyper - CVAD Regimen in Combination With Ofatumumab as Frontline Therapy for Patients With CD-20 Positive Acute Lymphoblastic Leukaemia
Phase of Trial: Phase II
Latest Information Update: 11 Jun 2017
At a glance
- Drugs Ofatumumab (Primary) ; Cyclophosphamide; Cytarabine; Cytarabine; Dexamethasone; Dexamethasone; Doxorubicin; Methotrexate; Methotrexate; Vincristine
- Indications Acute lymphoblastic leukaemia; Burkitt's lymphoma
- Focus Therapeutic Use
- 06 Jun 2017 Interim results (n=63) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 03 Apr 2017 Status changed from active, no longer recruiting to recruiting.
- 28 Mar 2017 Planned primary completion date changed from 1 Aug 2018 to 1 Jul 2019.